GBR
Bob Klaber
Kindness
Equity
population health
quality improvement
leadership development & learning
Consultant Paediatrician & Director of Strategy, Research & Innovation, Imperial College, Healthcare NHS Trust
Imperial College Healthcare NHS Trust

leadership vision

I am a children’s doctor and Executive Director within the NHS, who has always been drawn to work that goes beyond the walls of the hospital to improve the lives of people within our societies.

about me

Bob Klaber is a Consultant General Paediatrician & Director of Strategy, Research & Innovation at Imperial College Healthcare NHS Trust. Bob trained as an educationalist alongside his postgraduate paediatric training in London and has a strong interest in individual and systems learning, quality improvement, behavioural insights work, leadership development and kindness. He has completed a mixed methods MD researching leadership approaches in healthcare. Bob is also a member of the NHS Assembly.

In 2015 Bob set up a team who continue to drive an ambitious project to create a culture of continuous quality improvement across Imperial College Healthcare, has worked as Deputy Medical Director and led work on the development and implementation of the Trust's new organisational strategy. In his current Executive Director role he is responsible for strategy, research, innovation and improvement across the Trust. This also involves clinical leadership around redevelopment, sustainability, improving population health, developing the Trust's role as an anchor institution and reducing health inequalities.

Bob is also a strong advocate for child health and co-leads the Connecting Care for Children (CC4C) integrated child health programme in North West London www.cc4c.imperial.nhs.uk , which is focused on developing whole population integrated care models of care and learning within paediatrics and child health.

more fellows

GBR
Adrian Jonas
NHS England
Adrian Jonas
Chief Analyst for the North West Region, NHS England, United Kingdom
SUI
Sven Streit
University of Bern
Sven Streit
General Practitioner; Associate Professor in Primary Care, University of Bern, Switzerland
GER
Michael Moran
AbbVie GmbH & Co. KG
Michael Moran
Medical Director and Therapeutic Area Lead, Global Medical Affairs, AbbVie GmbH & Co. KG, Germany
GBR
Adam Doyle
Sussex Clinical Commissioning Groups
Adam Doyle
Chief Executive Officer/National Director - System Development, NHS Sussex/NHS England, United Kingdom
GBR
Timothy Taylor
NHSEI Midlands
Timothy Taylor
Associate Medical Director, NHSEI Midlands; Consultant Neuroradiologist, Nottingham University Hospitals NHS Trust, United Kingdom
GBR
Richard Stubbs
Yorkshire & Humber AHSN
Richard Stubbs
Chief Executive, Health Innovation Yorkshire & Humber and Chair, National Health Innovation Network, United Kingdom
GER
Wiebke Loebker
Federal Institute of Drugs and Medical Product
Wiebke Loebker
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
GER
Ulrike Streit
University Hospital Frankfurt
Ulrike Streit
Managing senior physician in radiology, The Klinikum rechts der Isar, The University Hospital of the Technical University of Munich, Germany
GBR
Rishi Das Gupta
Health Innovation Network (HIN)
Rishi Das Gupta
Chief Executive, Health Innovation Network (HIN), United Kingdom
GBR
Judith Proctor
Edinburgh Integration Joint Board
Judith Proctor
Chief Officer, Edinburgh Integration Joint Board, Scotland, United Kingdom
GBR
Helen Crimlisk
Sheffield Health & Social Care NHS Foundation Tr
Helen Crimlisk
Consultant Psychiatrist and Deputy Medical Director, Sheffield Health and Social Care NHS Foundation Trust, United Kingdom
SUI
Mario Desmedt
Swiss Nurse Leaders
Mario Desmedt
Nurse; Director of Nursing, Fondation Asile des Aveugles, Lausanne; President, Swiss Nurse Leaders Association, Switzerland
SUI
Ursula Bonhage
Stiftung Stöckenweid
Ursula Bonhage
CEO, Stiftung Stöckenweid
SUI
Carl Rudolf Blankart
University of Bern
Carl Rudolf Blankart
Professor of Regulatory Affairs, University of Bern, Switzerland
SUI
Andy Fischer
Medgate
Andy Fischer
CEO, Medgate, Switzerland
SUI
Nicola von Lutterotti
Self-employed
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany

Meet the Partners

Sciana: The Health Leaders Network is a programme supported jointly by the Health Foundation (UK), Careum (CH) and the Bosch Health Campus (DE) in collaboration with Salzburg Global.